China Kangtai Cactus Bio-Tech Inc (fka CKGT)

[MikeDDKing]

China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch

HARBIN, China, Sept. 10 /Xinhua-PR Newswire-FirstCall/ -- China Kangtai Cactus Biotech, Inc. (OTC Bulletin Board: CKGT), a vertically integrated grower, developer, manufacturer and marketer of a variety of cactus-based consumer products, announced today that the Company plans to launch a new
product: Cactus Health Cigarettes.

In order to develop a niche market, to welcome the green-themed 2008 Beijing Olympiad, and in an effort to take advantage of the public's increasing health awareness stimulated by this event, the Company has successfully researched and developed a smoking product that uses cactus as
its main ingredient: Cactus Health Cigarettes. The Company has applied for patent protection for the product at the China National Bureau of Intellectual Property and expects to gain approval before the end of the year. The Company believes that this product has huge market potential and that the sales of the product could have an extremely positive impact on Company's top and bottom lines. The Company has decided to launch the product in 2008.

Cactus Health Cigarettes
This product uses dried cactus palms as the main ingredient, together with dried honeysuckle, dried ginkgo leaves, and a small amount of a plant based essence, and is made through conventional cigarette production processes and technologies. This product is a new and healthy alternative
to conventional cigarettes.

The harmful effects of cigarette smoking and the difficulty to quit smoking are well known. Cigarette production and consumption are especially high in China. Large numbers of people die every year due to traditional nicotine cigarette-related diseases, and many also suffer from illnesses related to second-hand smoke. The launch of cactus health cigarettes is a Gospel to those who suffer miserably from smoking.

According to The Grand Dictionary of Chinese Medicine and the Compendium of Materia Medica, as well as many certified tests and analyses carried out by the Department of Agriculture and the Institute for Nutrition and Food Safety of the Center of Disease Prevention and Control of China, cacti contain over 18 kinds of amino acid, carbohydrates, chief meal fibrin, carotene, vitamin C, vitamin E, vitamin K1, vitamin B1, vitamin B2, vitamin B6, vitamin B12, smoke acid, folacin, calcium, phosphorus, iron, potassium, sodium, magnesium, manganese, copper, zinc, iodine, and selenium. Various cactus products have been shown to provide health benefits and have been used to treat a variety of health issues including, diabetes, adiposity, constipation, cholesterol, high blood pressure, low immunity, and various skin disorders.

China Kangtai owns nearly 400 acres of farmland and grows three species of Mexican cacti and some of the Company's own cloned species. The Company owns an R & D institute that has successfully produced 31 product patents, 15 of which have already been approved. It currently produces and sells
four cactus- based product categories: nutraceuticals, which are health and wellness dietary supplements; beverages, including juice, teas, beer, wine, and spirits; packaged foods, such as noodles, biscuits and pickles; and raw and intermediate cactus materials. There are about 36 existing products under these four categories.

Jinjiang Wang, Chief Executive Officer of China Kangtai Cactus Biotech commented, "Cactus-based products are well-received by the market in China and show huge growth potential. China Kangtai will continue to develop new products to meet the demand of the consumers, while penetrating the markets with its existing products."

Wang concluded, "Our Company remains focused on the quality and functionality of our products that deliver various health benefits to consumers. These new products will contribute positively to the Company's 2007 performance and beyond, and accelerate its revenue and profit growth. With 15 product patents and 16 pending approval, China Kangtai is the dominant player in the cactus-based consumer product sector."

About China Kangtai Cactus Bio-Tech Inc.
China Kangtai Cactus Bio-Tech, Inc. is a market-leading cactus grower and producer of cactus-related products with over 387 acres of plants and an active R&D group that holds 15 product patents and is seeking another 16 in a variety of product categories. China Kangtai's high-quality products are sold throughout China in supermarkets, food stores, hotels and restaurants through a growing distribution network that has currently covered 14 provinces and 4 municipalities.

Cautionary Statement Regarding Forward Looking Information
This press release contains forward-looking information about China Kangtai Cactus Bio-tech that is intended to be covered by the safe harbor for forward-looking statements provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology, and include discussions of strategy, and statements about industry trends and China Kangtai Cactus Bio-tech future performance, operations and products.

This forward-looking information should be considered only in connection with "Risk Factors" in China Kangtai Cactus Bio-tech's annual report on Form 10KSB filed with the SEC on April 2, 2007, and its other current and periodic reports filed with the SEC. China Kangtai Cactus Bio-tech assumes no obligations to update any forward-looking statements or information set forth in this press release.

For more information, please contact:

At the Company:

Ren Hu
Vice President
China Kangtai Cactus Bio-tech, Inc.
Phone: [phone]
Email: [e-mail]


Investor Relations:

RedChip Companies, Inc.
Jon Cunningham
Phone: +1-800-RedChip x107
Email: [e-mail] / [e-mail]
Website: http://www.RedChip.com



SOURCE China Kangtai Cactus Bio-tech, Inc.